You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Harvard Business School

Last Updated: April 10, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017373

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 017373 describes FLUOCINONIDE, which is a drug marketed by Acp Nimble, Amneal Pharms Llc, Cadila, Fougera Pharms Inc, Glenmark Generics, Perrigo Israel, Perrigo New York, Taro, Teligent Pharma Inc, Teva, Cnty Line Pharms, Fougera Pharms, Novel Labs Inc, Xiromed, Encube Ethicals, Glasshouse Pharms, Macleods Pharms Ltd, Teva Pharms, Zydus Pharms, Glenmark Pharms Ltd, and Taro Pharm Inds Ltd, and is included in forty-four NDAs. It is available from thirty-four suppliers. Additional details are available on the FLUOCINONIDE profile page.

The generic ingredient in FLUOCINONIDE is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
Summary for 017373
Applicant:Cnty Line Pharms
Formulation / Manufacturing:see details
Pharmacology for NDA: 017373
Medical Subject Heading (MeSH) Categories for 017373
Suppliers and Packaging for NDA: 017373
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLUOCINONIDE fluocinonide GEL;TOPICAL 017373 NDA Alvogen Inc. 47781-533 47781-533-26 1 TUBE in 1 CARTON (47781-533-26) > 60 g in 1 TUBE
FLUOCINONIDE fluocinonide GEL;TOPICAL 017373 NDA Alvogen Inc. 47781-533 47781-533-72 1 TUBE in 1 CARTON (47781-533-72) > 15 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.